These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3040340)

  • 41. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses.
    Owens JG; Kamerling SG; Stanton SR; Keowen ML; Prescott-Mathews JS
    Am J Vet Res; 1996 Jun; 57(6):866-74. PubMed ID: 8725815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of pirazolac in human subjects.
    Täuber U
    Drugs Exp Clin Res; 1990; 16(1):7-15. PubMed ID: 2376240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.
    Koup JR; Thomas D; Tucker E; Black A; Ruderman M; Dixon JA; Kinkel A
    Eur J Clin Pharmacol; 1988; 35(2):199-202. PubMed ID: 3191939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A; Montrull H; Meirovich CI
    Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Voltaren on arachidonic acid metabolism in arthritis patients.
    Liauw HL; Ku E; Brandt KD; Benson MD; Aldo-Benson MA; Waiter SL; Lee W; Chan K; Vyas K
    Agents Actions Suppl; 1985; 17():195-9. PubMed ID: 3937448
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential dosing study of pirazolac, a new non-steroidal anti-inflammatory agent, in patients with rheumatoid arthritis.
    Symmons D; Clark B; Panayi G; Geddawi M
    Curr Med Res Opin; 1985; 9(8):542-7. PubMed ID: 3896664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis.
    Wade CR; Jackson PG; Highton J; van Rij AM
    Clin Chim Acta; 1987 May; 164(3):245-50. PubMed ID: 3594915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification of leukotriene B4 in synovial fluid by gas chromatography/tandem mass spectrometry.
    Dawson M; McGee CM; Brooks PM; Vine JH; Watson TR
    Biomed Environ Mass Spectrom; 1988 Sep; 17(3):205-11. PubMed ID: 2850829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
    Vardar S; Buduneli E; Baylas H; Berdeli AH; Buduneli N; Atilla G
    J Periodontol; 2005 Jan; 76(1):99-106. PubMed ID: 15830643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The status of various indicators of the protease inhibitor system in blood and synovial fluid in rheumatoid arthritis].
    Danilova TG; Platonova LV; Paskhina TS
    Vopr Med Khim; 1993; 39(3):40-3. PubMed ID: 8101408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis.
    Caruso I; Moro E; Patrono C; Sacchetti G; Tamassia V; Tosolini GP
    Scand J Rheumatol; 1980; 9(2):123-6. PubMed ID: 7433927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
    Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukotriene B4 in synovial fluid.
    Davidson EM; Rae SA; Smith MJ
    J Pharm Pharmacol; 1982 Jun; 34(6):410. PubMed ID: 6124631
    [No Abstract]   [Full Text] [Related]  

  • 57. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.
    Aked DM; Foster SJ
    Br J Pharmacol; 1987 Nov; 92(3):545-52. PubMed ID: 2827824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
    Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
    Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prostaglandin and leukotriene release of synovial tissue in various joint diseases].
    Wittenberg RH; Willburger RE; Kleemeyer KS; Schleberger R
    Z Orthop Ihre Grenzgeb; 1991; 129(6):531-6. PubMed ID: 1837403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.